Pooled HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resource-limited setting

Journal of Acquired Immune Deficiency Syndromes

Volumn 64, Issue 2, 2013, Pages 134-137

  Pannus, Pieter ^a   Fajardo, Emmanuel ^a   Metcalf, Carol ^a   Coulborn, Rebecca M ^a   Durán, Laura T ^a   Bygrave, Helen ^a   Ellman, Tom ^a   Garone, Daniela ^a   Murowa, Michael ^b   Mwenda, Reuben ^b   Reid, Tony ^c   Preiser, Wolfgang ^d  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MINISTRY OF HEALTH   (Malawi)

^c MÉDECINS SANS FRONTIÈRES   (Belgium)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

DBS; Finger prick; HIV; Operational research; Pooling; Resource limited setting; Viral load

Indexed keywords

ACCURACY; ADULT; CONFERENCE PAPER; COST; DRIED BLOOD SPOT TESTING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MONITORING; PLASMA; PRIORITY JOURNAL; PUBLIC HOSPITAL; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; DRIED BLOOD SPOT TESTING; DRUG MONITORING; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALAWI; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VIRAL LOAD;

EID: 84885312513     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182a61e63     Document Type: Conference Paper

References (20)

1. World Health Organization (WHO). Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2013. Available at: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf. Accessed July 17, 2013.
2. Lynen L, Van Griensven J, Elliott J. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings. Curr Opin HIV AIDS. 2010;5: 1-5.
3. Keiser O, Chi B, Gsponer T, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS. 2011;25: 1761-1769.
4. Van Oosterhout JJ, Brown L, Weigel R, et al. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop Med Int Health. 2009;14: 856-861.
5. Kantor R, Diero L, Delong A, et al. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis. 2009; 49: 454-462.
6. Sigaloff KC, Hamers RL, Wallis CL, et al. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. J Acquir Immune Defic Syndr. 2011;58: 23-31.
7. ART-LINC of IeDEA Study Group, Keiser O, Tweya H, Boulle A, et al. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS. 2009;23: 1867-1874.
8. UNAIDS, Médecins Sans Frontières: Speed Up Scale-up: Strategies, Tools and Policies to Get the Best HIV Treatment to More People, Sooner. Geneva, Switzerland: MSF Access Campaign; 2012.
9. Roberts T, Bygrave H, Fajardo E, et al. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc. 2012;15: 17324.
10. Johannessen A. Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanalysis. 2010;2: 1893-1908.
11. Metcalf C, Fajardo E, Pannus P, et al. Use of finger-prick dried blood spots for quantifying HIV-1 viral load: a diagnostic accuracy study conducted in Thyolo, Malawi. Paper presented at: 20th Conference on Retroviruses and Opportunistic Infections; March 3-6, 2013; Atlanta, GA. Abstract 608.
12. Smith D, May S, Perez-Santiago J, et al. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS. 2009; 23: 2151-2158.
13. May S, Gamst A, Haubrich R, et al. Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. J Acquir Immune Defic Syndr. 2010;53: 194-201.
14. Tilghman MW, Guerena DD, Licea A, et al. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. J Acquir Immune Defic Syndr. 2011;56: 70-74.
15. Van Zyl G, Preiser W, Potschka S, et al. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis. 2011;52: 264-270.
16. Kim H, Ku N, Kim S, et al. Pooled nucleic acid testing to identify ART failure during HIV infection in a tertiary teaching hospital: Seoul, South Korea. Paper presented at: 20th Conference on Retroviruses and Opportunistic Infections; 2013; Atlanta, GA. Abstract 611.
17. Chohan B, Tapia K, Merkel M, et al. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan Children. J Acquir Immune Defic Syndr. 2013;63:e87-e93.
18. Malawi Demographic and Health Survey 2010. National Statistical Office, Zomba, Malawi.
19. Médecins Sans Frontières Access Campaign. Putting HIV Treatment to the Test: A Product Guide for Viral Load and Point-of-Care CD4 Diagnostic Tools. Geneva, Switzerland: MSF; 2013. Available at: http://www.msfaccess.org/content/putting-hiv-treatment-test. Accessed July 17, 2013.
20. UNITAID. HIV/AIDS Diagnostic Technology Landscape. 2nd ed. Geneva, Switzerland: World Health Organisation; 2012. Available at: http://www.unitaid. eu/images/marketdynamics/publications/UNITAIDHIV- Diagnostics-Landscape-2nd- edition.pdf. Accessed March 6, 2013.